Sight Sciences, Inc.
4040 Campbell Avenue
Suite 100
Menlo Park, CA 94025
United States
877 266 1144
https://www.sightsciences.com
版塊: Healthcare
行業: Medical Devices
全職員工: 214
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Paul Badawi | Co-Founder, President, CEO & Director | 871.59k | 無 | 1975 |
| Dr. David Badawi M.D. | Founder, CTO & Director | 無 | 無 | 1970 |
| Ms. Alison Perry Bauerlein | CFO & Treasurer | 378.6k | 無 | 1981 |
| Mr. Matthew W. Link | Chief Commercial Officer | 157.61k | 無 | 1975 |
| Mr. Sam Boong Park | Chief Operating Officer | 531.78k | 無 | 1961 |
| Mr. Jeremy B. Hayden | Chief Legal Officer | 無 | 無 | 1970 |
| Mr. Steve R. Tamayo Jr. | VP and Chief Ethics & Compliance Officer | 無 | 無 | 無 |
| Dr. Reay H. Brown M.D. | Chief Medical Officer | 無 | 無 | 無 |
| Mr. Stephen B. Thau J.D. | Secretary | 無 | 無 | 無 |
| Mr. Jim Rodberg | VP of Finance & Corporate Controller | 無 | 無 | 無 |
描述
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
公司管治
截至 2024年5月1日 止，Sight Sciences, Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：3；董事會：5；股東權利：8；現金賠償：10。
